Education
About Us
Working with TipRanks
Follow Us
ProMIS Neurosciences (PMN)
NASDAQ:PMN
Pmn310
Alzheimer Disease, Early Onset
Phase I
Recruiting
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
Dec 16, 2024
―
Pmn310
Healthy Participants
Phase I
Completed
A Phase 1a Study of PMN310 In Healthy Volunteers
Oct 23, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does ProMIS Neurosciences (PMN) have in its pipeline
PMN is currently developing the following drugs: Pmn310, Pmn310. These drug candidates are in various stages of clinical development as the company works toward FDA approval.